Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Thyroid Cancer Clinical Trials

100 recruiting trials for Thyroid Cancer. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
6
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGPhase 1NCT04119024

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic...

This phase I trial studies the side effects and best dose of modified immune cells (IL13Ralpha2 CAR T cells) after a chemotherapy conditioning regimen for the treatment of...

Sponsor: Anusha KalbasiEnrolling: 183 locations
RECRUITINGNCT07389512

Pharmaceutical Management in Targeted Radioligand Therapy

Targeted Radionuclide Therapy (TRT) is a treatment modality used in nuclear medicine to target cancer cells while preserving surrounding healthy tissues. This approach is based on...

Sponsor: Hospices Civils de LyonEnrolling: 6003 locations
RECRUITINGNCT06729762

Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules

To evaluate long-term outcomes of ultrasound-guided thermal ablation for benign thyroid nodules

Sponsor: Chinese PLA General HospitalEnrolling: 15001 location
RECRUITINGNCT07359586

Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia

This study retrospectively analyzed patients who underwent tracheal intubation under general anesthesia at the First Affiliated Hospital of Zhejiang University School of Medicine...

Sponsor: Zhejiang UniversityEnrolling: 12002 locations
RECRUITINGPhase 2NCT06970353

Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer

This phase II trial evaluates Tunlametinib (MEK inhibitor) ± PD-1 in NRAS-mutant advanced thyroid cancer. Key Objectives: Assess efficacy (ORR by RECIST v1.1) Evaluate safety...

Sponsor: Fudan UniversityEnrolling: 401 location
RECRUITINGPhase 4NCT05830500

Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma

This is a real world study aiming to observe the efficacy and safety of Anlotinib capsules in patients with advanced medullary thyroid carcinoma, and to summarize the treatment...

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Enrolling: 36019 locations
RECRUITINGNCT06463756

AI Models to Predict Thyroid Cartilage Invasion in Laryngeal Carcinoma

This retrospective study was to develop and verify CT-based AI model to preoperatively predict the thyroid cartilage invasion of laryngeal cancer patients, so as to provide more...

Sponsor: First Affiliated Hospital of Chongqing Medical UniversityEnrolling: 4001 location
RECRUITINGPhase 2NCT06482086

Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

The current study aims to explore the potential advantages of anti-cancer therapy that is implemented based on drug sensitivity testing. This pertains to individuals with locally...

Sponsor: West China HospitalEnrolling: 751 location
RECRUITINGPhase 3NCT06475989

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

This phase III trial compares the effect of cabozantinib versus combination dabrafenib and trametinib for the treatment of patients with differentiated thyroid cancer that does...

Sponsor: ECOG-ACRIN Cancer Research GroupEnrolling: 26420 locations
RECRUITINGNCT06623500

Iodine Nutrition Status and Clinical Characteristics of Thyroid Cancer

The effect of iodine nutritional status on thyroid cancer has been controversial for many years. We designed a prospective cohort study that recruiting patients in different...

Sponsor: Shandong Provincial HospitalEnrolling: 16001 location
RECRUITINGNCT01005654

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Background: * Endocrine neoplasms (tumors) are among the fastest growing tumors in incidence in the United States. Furthermore, it is often difficult to distinguish between...

Sponsor: National Cancer Institute (NCI)Enrolling: 24151 location
RECRUITINGNCT04666103

Function Integrity of Neck Anatomy in Thyroid Surgery

Recent trends in the management of patients with low-risk papillary thyroid carcinoma who have a nonsuspicious or cytologically benign contralateral nodule call into question the...

Sponsor: Wuhan UniversityEnrolling: 12641 location
RECRUITINGNCT05765695

Radiofrequency Ablation in TIR3A Nodules With Negative Genetic Evaluation

The goal of this clinical trial is to demonstrate that TIR3A nodules with negative genetic test can be safely and effectively treated by radiofrequency ablation, with nodular...

Sponsor: Istituto Auxologico ItalianoEnrolling: 301 location
RECRUITINGNCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and...

Sponsor: Sanguine BiosciencesEnrolling: 200001 location
RECRUITINGNCT05024929

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Papillary thyroid cancer (PTC) is a common type of differentiated thyroid cancer (DTC) in children and represents the second most common cancer in adolescent females. Recently...

Sponsor: Children's Hospital of PhiladelphiaEnrolling: 329 locations
RECRUITINGNCT07357571

Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced...

Similarly, the burden of central lymph node metastasis affects the individualized management of patients with T1N0M0 papillary thyroid carcinoma (PTC): lymph node metastasis is a...

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityEnrolling: 6002 locations
RECRUITINGEarly Phase 1NCT06632860

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors

The US FDA approved a targeted somatostatin receptor 2 imaging agent, 68Ga-DOTATATE, in 2016. It has higher uptake in small cell lung cancer, pulmonary carcinoid, and medullary...

Sponsor: Peking Union Medical College HospitalEnrolling: 401 location
RECRUITINGNCT07436455

F-18 Tetrafluoroborate PET/CT in Differentiated Thyroid Cancer

In patients who have undergone surgery for differentiated thyroid cancer and who demonstrate elevated serum Tg and/or ATg levels during follow-up after radioactive iodine therapy,...

Sponsor: Ankara UniversityEnrolling: 502 locations
RECRUITINGNCT06779747

Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology

Observational single-center prospective and retrospective, nonpharmacological, spontaneous cohort study.

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di BolognaEnrolling: 58501 location
RECRUITINGPhase 1NCT03093909

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Any time the words "you," "your," "I," or "me" appear, it is meant to apply to the potential participant. The goal of this clinical research study is to find the highest...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 441 location
RECRUITINGPhase 3NCT06554652

Selective Neck Dissection Versus Modified Neck Dissection in PTC

This study is a phase III, randomized controlled, open label non inferiority study. Patients who meet the inclusion criteria are randomly assigned 1:1 to either the experimental...

Sponsor: Fudan UniversityEnrolling: 2501 location
RECRUITINGNCT05172921

Environmental Factors and Thyroid Cancer

Thyroid cancer incidence has been steadily increasing and has nearly tripled since the 1970's in the US and worldwide. Early detection of small, papillary thyroid cancers using...

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 5001 location
RECRUITINGPhase 2NCT06959641

XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

This phase II trial tests how well XL092 works for the treatment of patients with differentiated thyroid cancer that has not responded to previous treatment with radioiodine...

Sponsor: Northwestern UniversityEnrolling: 331 location
RECRUITINGNCT07046546

Thyroid Artery Goitre Embolization Trial A Pilot Study Investigating Thyroid Artery Embolisation as a Treatment for...

Large non-cancerous thyroid nodules (lumps in the thyroid gland) can cause pressure or discomfort in the neck or cosmetic issues. The standard treatment options include...

Sponsor: Royal Berkshire NHS Foundation TrustEnrolling: 101 location
RECRUITINGPhase 1 / Phase 2NCT05451602

HEC169096 in Participants With Advanced Solid Tumors

An Open, Multi-Center Phase I/II Clinical Study To Evaluate The Safety, Tolerability, Pharmacokinetic Characteristics And Effectiveness Of HEC169096 In Patients With Thyroid...

Sponsor: Sunshine Lake Pharma Co., Ltd.Enrolling: 4561 location
RECRUITINGNCT05733013

A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer

The purpose of this study to learn more about the use of redifferentiating medications as a standard treatment for radioactive iodine/RAI-refractory thyroid cancer. This study is...

Sponsor: Memorial Sloan Kettering Cancer CenterEnrolling: 1001 location
RECRUITINGPhase 1 / Phase 2NCT06814496

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Phase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24 patients with...

Sponsor: University of ArizonaEnrolling: 301 location
RECRUITINGPhase 3NCT06791005

A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.

The detection rate of thyroid cancer (PTC) has increased rapidly in recent years. Except undifferentiated cancer, surgery is still one of the most important treatments for all...

Sponsor: Second Affiliated Hospital of Xi'an Jiaotong UniversityEnrolling: 4001 location
RECRUITINGNCT06623578

Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC

Thyroid cancer is one of the most common malignant tumors in women, ranking seventh in the United States and fourth in China. Papillary thyroid carcinoma is the most common...

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityEnrolling: 8761 location
RECRUITINGPhase 2NCT06087068

Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma

Papillary thyroid carcinoma (PTC) is the most common thyroid cancer and has a good prognosis.According to the 2015 American thyroid association (ATA) guidelines, no gross...

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical SciencesEnrolling: 1401 location
RECRUITINGNCT07328243

Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A...

This is a single-arm, open-label, multicenter, exploratory clinical trial designed to systematically evaluate the efficacy, safety, and patient benefit of ultrasound-guided...

Sponsor: Tian'an JiangEnrolling: 851 location
RECRUITINGNCT07287176

Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System

The primary objective of this study is to reproduce in a multi-center study results obtained during the feasibility First-In-Human (FIH) study with Prof. Stefano Spiezia, MD...

Sponsor: Pulse Biosciences, Inc.Enrolling: 1002 locations
RECRUITINGNCT07010380

Dual-Channel Near-Infrared Autofluorescence Imaging and AI Analysis to Locate Parathyroid Glands (PTFinder)

This study tests PTFinder, a dual-camera system that makes parathyroid glands glow on screen by capturing their natural near-infrared autofluorescence. After a thyroid or...

Sponsor: Bo Wang,MDEnrolling: 1801 location
RECRUITINGNCT06929650

The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer

The goal of this clinical trial is to test radiofrequency ablation (RFA) in thyroid cancers ≤2 cm in diameter. The main question it aims to answer is: • What is the feasibility...

Sponsor: University Health Network, TorontoEnrolling: 401 location
RECRUITINGNCT07059507

Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy.

The prevalence of incidental thyroid cancer (ITC) in Graves' Disease (GD) patients undergoing thyroidectomy appears higher than historically believed, potentially exceeding 10% in...

Sponsor: Minia UniversityEnrolling: 2801 location
RECRUITINGPhase 2NCT06790706

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the...

Immune checkpoint inhibitors (ICI) have revolutionized the management of advanced cancers. However, most rare cancers have been excluded from this progress due to the lack of...

Sponsor: Hospices Civils de LyonEnrolling: 15415 locations
RECRUITINGNCT06849284

To Perform a Post-market Study of the Performance of the Idylla ThyroidPrint Assay Using Clinical Samples in Predicting...

To perform a post-market study of the performance of the Idylla™ ThyroidPrint® Assay using clinical samples in predicting the nature of indeterminate thyroid nodules (ITNs) across...

Sponsor: Royal Cornwall Hospitals TrustEnrolling: 1001 location
RECRUITINGPhase 2NCT05668962

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

This research is being done to determine the efficacy of selpercatinib to restore radioactive iodine (I-131 NaI) uptake and allow for I-131 treatment in people with RET...

Sponsor: Massachusetts General HospitalEnrolling: 306 locations
RECRUITINGNCT07259304

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

This study assesses how personal relationships (such as friendships, family relationships, or romantic partners) influence the physical activity (exercise) and well-being of young...

Sponsor: University of Southern CaliforniaEnrolling: 2501 location
RECRUITINGNCT07419932

Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer

This multicenter observational study aims to evaluate the safety and efficacy of neoadjuvant therapy in patients with locally advanced thyroid cancer, focusing on imaging,...

Sponsor: Fujian Medical UniversityEnrolling: 1201 location
RECRUITINGPhase 2NCT06787911

Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer

This study is a single-arm intervention study. Locally advanced differentiated thyroid carcinoma patients receive neoadjuvant therapy with Donafenib and PD-1 antibody Sintilimab...

Sponsor: Yu WangEnrolling: 141 location
RECRUITINGEarly Phase 1NCT06898437

Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer

177Lu-LNC1004 Injection, a radiopharmaceutical targeting FAP, has demonstrated preliminary antitumor effect in advanced FAP-positive solid tumor patients. The primary purpose of...

Sponsor: Peking Union Medical College HospitalEnrolling: 201 location
RECRUITINGPhase 1NCT03975231

Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer

This trial studies how well dabrafenib, trametinib, and intensity modulated radiation therapy (IMRT) work together in treating patients with BRAF mutated anaplastic thyroid...

Sponsor: City of Hope Medical CenterEnrolling: 63 locations
RECRUITINGNCT03765333

GETNE Registration of Thyroid Cancer

An epidemiological, observational, multicenter, cross-sectional, retrospective study on patients ≥ 18 years visited in the oncology services of the participating centers with...

Sponsor: Grupo Espanol de Tumores NeuroendocrinosEnrolling: 201 location
RECRUITINGNCT05229341

Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules

This clinical trial evaluates deoxyribonucleic acid (DNA) methylation signatures in diagnosing and managing thyroid nodules. The purpose of this research is to develop a new test...

Sponsor: City of Hope Medical CenterEnrolling: 14501 location
RECRUITINGPhase 2NCT06458036

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical...

Sponsor: Children's Hospital of PhiladelphiaEnrolling: 132 locations
RECRUITINGNCT05604963

Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers

This is a multi-centre, randomised, non-inferiority, phase III study in patients with low risk differentiated thyroid cancer. Patients will be identified via oncology...

Sponsor: University College, LondonEnrolling: 45620 locations
RECRUITINGNCT03892993

Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or...

This trial develops and studies how well a patient decision aid works in supporting decision-making about when to start or stop new drugs, join clinical trials, or continue active...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 1201 location
RECRUITINGPhase 2NCT06362694

Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on...

This pilot phase 2 study evaluates the effectiveness and safety of the Rechallenge concept in patients with BRAF-positive anaplastic thyroid cancer after progression on anti-BRAF...

Sponsor: Saint Petersburg State University, RussiaEnrolling: 101 location
RECRUITINGNCT07218315

Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma

This study is to evaluate the effectiveness of nsPFA in treating papillary thyroid microcarcinoma. T

Sponsor: M.D. Anderson Cancer CenterEnrolling: 152 locations

Showing 50 of 100 trials.Search all Thyroid Cancer trials